Hydroxyethyl starch - Wikipedia, the free encyclopedia
So for example, one commercially available hydroxyethyl starch (Voluven) is described as 6% HES 130 / 0.4. The elimination depends on molar substitution degree.
Blood substitutes - Wikipedia, the free encyclopedia
These may be crystalloid-based (Ringer's lactate, normal saline, D5W (dextrose 5% in water) or colloid-based (Voluven, Haemaccel, Gelofusin). Oxygen therapeutics: mimic human blood's ...
Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4 ...
1: Anesth Analg. 2001 Apr;92(4):855-62. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than ...
What is in this leaflet
October, 2006 CMI for Voluven 6% Filename:VolCMI061106-clean Page 1 of 2 Changes: TGA approval. Voluven 6% Pentastarch Consumer Medicine Information What is in this leaflet This ...
FDA Approvals: Cialis, Voluven, Vyvanse
: The FDA has approved a new dosage regimen for tadalafil tablets, 6% hydroxyethyl starch in normal saline intravenous infusion, and new dosage strengths for lisdexamfetamine ...
ProjectDisaster » Blog Archive » FDA: Voluven approved to prevent ...
A place for the latest news, information and discussion regarding disasters, terrorism, emerging infectious diseases, disaster response, mitigation and preparedness!
Voluven - 2007 FDA approvals - FierceBiotech
Drug: Voluven Indication: Significant blood loss Company: Fresenius Kabi Approval Date: December 27, 2007 Scoop: Voluven, an intravenous solution that prevents and treats a ...
Voluven Helps Minimize Surgical Blood Loss
A 'blood volume expander' ... THURSDAY, Dec. 27 (HealthDay News) -- Voluven was approved Thursday by the U.S. Food and Drug Administration to prevent and treat significant loss of ...
FDA Approves Voluven To Treat Serious Blood Volume Loss During And ...
The U.S. Food and Drug Administration today approved Voluven, an intravenous solution that prevents and treats a dangerous loss of blood volume, a condition that sometimes occurs ...
Fresenius' Voluven Approved in U.S.
The FDA has approved Voluven, an IV solution that prevents and treats a dangerous loss of blood volume, a condition that sometimes occurs during and after surgery.
FDA Approves Voluven to Treat Serious Blood Volume Loss following ...
The U.S. Food and Drug Administration today approved Voluven, an intravenous solution that prevents and treats a dangerous loss of blood volume, a condition that sometimes occurs ...
[The design of the VISEP trial. Critical appraisal]
1: Anaesthesist. 2007 Jan;56(1):71-7. [The design of the VISEP trial. Critical appraisal] [Article in German] Zander R, Boldt J, Engelmann L, Mertzlufft F, Sirtl C, Stuttmann R.
